{
  "url": "https://finance.yahoo.com/news/high-growth-tech-stocks-asia-043751648.html?_guc_consent_skip=1754975272",
  "authorsByline": "Simply Wall St",
  "articleId": "aab2b4e7dabe41d292bec9f9b56351b9",
  "source": {
    "domain": "finance.yahoo.com",
    "location": {
      "country": "us",
      "state": "CA",
      "county": "Santa Clara County",
      "city": "Sunnyvale",
      "coordinates": {
        "lat": 37.3688301,
        "lon": -122.036349
      }
    }
  },
  "imageUrl": "https://media.zenfs.com/en/simply_wall_st__316/2bc7e9c938f83604e86f7ffd61b40d2a",
  "country": "us",
  "language": "en",
  "pubDate": "2025-08-12T04:37:51+00:00",
  "addDate": "2025-08-12T05:08:17.164997+00:00",
  "refreshDate": "2025-08-12T05:08:17.164999+00:00",
  "score": 1.0,
  "title": "High Growth Tech Stocks In Asia With Promising Potential",
  "description": "The Asian tech market is experiencing notable growth, with indices such as the Nasdaq Composite reaching new highs and Chinese exports showing resilience despite global trade tensions. In this dynamic environment, identifying promising tech stocks involves looking for companies that demonstrate strong innovation capabilities and adaptability to shifting economic conditions.",
  "content": "The Asian tech market is experiencing notable growth, with indices such as the Nasdaq Composite reaching new highs and Chinese exports showing resilience despite global trade tensions. In this dynamic environment, identifying promising tech stocks involves looking for companies that demonstrate strong innovation capabilities and adaptability to shifting economic conditions. Click here to see the full list of 174 stocks from our Asian High Growth Tech and AI Stocks screener. Underneath we present a selection of stocks filtered out by our screen. Overview: Essex Bio-Technology Limited is an investment holding company that develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally with a market capitalization of approximately HK$3.16 billion. Operations: Essex Bio-Technology generates revenue primarily from its surgical and ophthalmology segments, with HK$879.90 million and HK$771.49 million respectively. The company also provides services contributing HK$18.42 million to its revenue stream. Essex Bio-Technology has demonstrated a robust trajectory in the biotech sector, with its revenue and earnings growth outpacing the broader Hong Kong market. The company's annual revenue is expected to increase by 10.2%, surpassing the market's 8.1% growth rate, while its earnings are forecasted to climb at an impressive rate of 12% annually, compared to the market's 10.8%. Despite not outperforming the biotech industry\u2019s average last year, Essex maintains a promising outlook with a projected Return on Equity of 22.5%. Additionally, recent corporate developments include a dividend increase and amendments to its bylaws which could enhance governance structures and shareholder returns moving forward.\n\u2022 Get an in-depth perspective on Essex Bio-Technology's performance by reading our health report here. SEHK:1061 Revenue and Expenses Breakdown as at Aug 2025 Overview: WuXi Xinje Electric Co., Ltd. focuses on developing, producing, and selling industrial automation products both in China and internationally, with a market cap of CN\u00a58.81 billion.",
  "medium": "Article",
  "links": [
    "https://simplywall.st/company/id/6728b25c-0acb-4f2f-853f-a44304ab62c8/past?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=3982594",
    "https://simplywall.st/discover/investing-ideas/10228/fast-growing-stocks-with-high-insider-ownership/global?utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo&blueprint=3982594",
    "https://simplywall.st/discover/investing-ideas/168/undervalued-stocks-based-on-cash-flows/global?utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo&blueprint=3982594",
    "https://simplywall.st/company/id/a19b6937-cbb0-46bd-81fc-c3064ac9b509/past?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=3982594",
    "https://simplywall.st/company/id/51111a05-86d2-493b-bae2-9c04f7524ca4?utm_medium=finance_user&utm_campaign=cta&utm_source=yahoo&blueprint=3982594",
    "https://simplywall.st/portfolio?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=3982594",
    "https://simplywall.st/company/id/a19b6937-cbb0-46bd-81fc-c3064ac9b509?utm_medium=finance_user&utm_campaign=cta&utm_source=yahoo&blueprint=3982594",
    "https://simplywall.st/company/id/6728b25c-0acb-4f2f-853f-a44304ab62c8?utm_medium=finance_user&utm_campaign=cta&utm_source=yahoo&blueprint=3982594",
    "https://simplywall.st/company/id/51111a05-86d2-493b-bae2-9c04f7524ca4/past?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=3982594",
    "https://feedback.simplywall.st/article/Mzk4MjU5NDo4ZWRhOGVkNTM1YzY4OTE5",
    "https://simplywall.st/discover/investing-ideas/152/undiscovered-gems-with-strong-fundamentals/global?utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo&blueprint=3982594",
    "https://simplywall.st/discover/investing-ideas/215171/high-growth-tech-and-ai-stocks/global?utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo&blueprint=3982594"
  ],
  "labels": [],
  "claim": "",
  "verdict": "",
  "keywords": [
    {
      "name": "Essex Bio-Technology",
      "weight": 0.10380781
    },
    {
      "name": "Essex Bio-Technology Limited",
      "weight": 0.1005758
    },
    {
      "name": "High Growth Tech Stocks",
      "weight": 0.09756783
    },
    {
      "name": "promising tech stocks",
      "weight": 0.09591949
    },
    {
      "name": "Essex Bio",
      "weight": 0.08355988
    },
    {
      "name": "stocks",
      "weight": 0.07546758
    },
    {
      "name": "revenue",
      "weight": 0.07531225
    },
    {
      "name": "notable growth",
      "weight": 0.074206464
    },
    {
      "name": "Essex Bio-Technologys performance",
      "weight": 0.0682652
    },
    {
      "name": "Essex Bio-Technologys",
      "weight": 0.06621775
    }
  ],
  "topics": [
    {
      "name": "Markets"
    }
  ],
  "categories": [
    {
      "name": "Finance"
    }
  ],
  "taxonomies": [
    {
      "name": "/News/Business News/Financial Markets News",
      "score": 0.97998046875
    },
    {
      "name": "/News/Business News/Company News",
      "score": 0.95166015625
    },
    {
      "name": "/Finance/Investing/Stocks & Bonds",
      "score": 0.9482421875
    },
    {
      "name": "/Business & Industrial/Pharmaceuticals & Biotech",
      "score": 0.486572265625
    }
  ],
  "sentiment": {
    "positive": 0.78148544,
    "negative": 0.021153843,
    "neutral": 0.19736071
  },
  "summary": "The Asian tech market is experiencing significant growth, with indices reaching new highs and Chinese exports showing resilience despite global trade tensions. Essex Bio-Technology Limited, an investment holding company that produces, manufactures, and sells biologic drugs in China, Hong Kong, and internationally, generates revenue primarily from its surgical and ophthalmology segments. Despite not outperforming the biotech industry's average last year, Essex maintains a promising outlook with a projected Return on Equity of 22.5%. Recent corporate developments include a dividend increase and amendments to its bylaws.",
  "shortSummary": "The Asian tech market is experiencing significant growth with promising tech stocks like Essex Bio-Technology and WuXi Xinje Electric offering promising prospects despite ongoing economic challenges.",
  "translation": "",
  "translatedTitle": "",
  "translatedDescription": "",
  "translatedSummary": "",
  "reprint": true,
  "reprintGroupId": "86a2410e1ac547c6906c8b9cf9024ed8",
  "places": [],
  "scraped_sources": [
    {
      "url": "https://simplywall.st/discover/investing-ideas/215171/high-growth-tech-and-ai-stocks/global?utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo&blueprint=3982594",
      "text": "Results\n347\nCompanies within the technology and artificial intelligence (AI) sector, that exhibit significant growth potential, providing opportunities to capitalize on the rapid advancement and innovation within the industry.\n347 companies\nGold Circuit Electronics\nMarket Cap: NT$214.4b\nDesigns, manufactures, processes, and distributes printed circuit boards in Taiwan.\n2368\nNT$440.50\n7D\n21.7%\n1Y\n112.8%\nShengyi Electronics\nMarket Cap: CN\u00a544.8b\nEngages in the research and development, production, and sales of various printed circuit boards in China.\n688183\nCN\u00a554.87\n7D\n7.7%\n1Y\n160.4%\nShanghai Huace Navigation Technology\nMarket Cap: CN\u00a528.9b\nShanghai Huace Navigation Technology Ltd.\n300627\nCN\u00a537.02\n7D\n2.6%\n1Y\n81.4%\nCARsgen Therapeutics Holdings\nMarket Cap: HK$11.2b\nAn investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies, solid tumors, and autoimmune diseases in China.\n2171\nHK$21.00\n7D\n2.6%\n1Y\n434.4%\nCD Projekt\nMarket Cap: z\u014225.6b\nTogether its subsidiaries, engages in the development, publishing, and digital distribution of video games for personal computers and video game consoles in Poland.\nCDR\nz\u0142255.80\n7D\n3.4%\n1Y\n50.1%\neWeLLLtd\nMarket Cap: JP\u00a536.9b\nDevelops business support cloud services for visiting nursing stations in Japan.\n5038\nJP\u00a52,441.00\n7D\n2.8%\n1Y\n73.1%\nCircle Internet Group\nMarket Cap: US$36.2b\nOperates as a platform, network, and market infrastructure for stablecoin and blockchain applications.\nCRCL\nUS$161.17\n7D\n-2.2%\n1Y\nn/a\nIntellego Technologies\nMarket Cap: SEK 4.6b\nManufactures and sells colorimetric ultraviolet indicators in Sweden.\nINT\nSEK 150.80\n7D\n6.2%\n1Y\n446.4%\nKebNi\nMarket Cap: SEK 599.3m\nDevelops, produces, and sells products and applications for stabilization, navigation, and satcom worldwide.\nKEBNI B\nSEK 2.21\n7D\n-7.9%\n1Y\n51.8%\nTips Music\nMarket Cap: \u20b974.6b\nEngages in the acquisition and exploitation of music rights in India and internationally.\nTIPSMUSIC\n\u20b9583.95\n7D\n1.5%\n1Y\n-21.8%\nFositek\nMarket Cap: NT$70.3b\nEngages in the manufacture and wholesale of electronic materials and components.\n6805\nNT$1,025.00\n7D\n10.3%\n1Y\n45.0%\nNayax\nMarket Cap: \u20aa5.7b\nA fintech company, develops a complete solution for automated self-service retailers, commerce, and other merchants in the United States, Europe, the United Kingdom, Australia, Israel, and rest of the world.\nNYAX\n\u20aa155.00\n7D\n4.0%\n1Y\n87.9%\nHacksaw\nMarket Cap: SEK 19.8b\nOperates as a B2B technology platform and game development company.\nHACK\nSEK 68.50\n7D\n-8.7%\n1Y\nn/a\nAccton Technology\nMarket Cap: NT$570.1b\nResearches and develops, manufactures, and sells network communication equipment in Taiwan, America, rest of Asia, Europe, and internationally.\n2345\nNT$1,020.00\n7D\n15.3%\n1Y\n100.4%\nEoptolink Technology\nMarket Cap: CN\u00a5191.4b\nEngages in the research and development, production and sales of optical modules in China and internationally.\n300502\nCN\u00a5192.89\n7D\n4.5%\n1Y\n183.0%\nEcho IQ\nMarket Cap: AU$132.6m\nProvides artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia and the United Kingdom.\nEIQ\nAU$0.20\n7D\n-4.7%\n1Y\n41.4%\nPharmaEssentia\nMarket Cap: NT$166.3b\nA biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.\n6446\nNT$499.00\n7D\n0.1%\n1Y\n-29.5%\nZhejiang Lante Optics\nMarket Cap: CN\u00a511.3b\nManufactures and sells optical products in China.\n688127\nCN\u00a528.02\n7D\n2.4%\n1Y\n63.9%\nSystems\nMarket Cap: PK\u20a8201.8b\nEngages in the software development and trading, hardware, and business process outsourcing (BPO) service businesses in Pakistan, North America, the Middle East, Africa, Europe, the Asia Pacific, and internationally.\nSYS\nPK\u20a8137.50\n7D\n0.2%\n1Y\n62.0%\nBonesupport Holding\nMarket Cap: SEK 20.4b\nAn orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.\nBONEX\nSEK 310.40\n7D\n-4.1%\n1Y\n12.0%\nNaruida Technology\nMarket Cap: CN\u00a514.0b\nManufactures and sells polarized multifunctional active phased array radars in China.\n688522\nCN\u00a546.23\n7D\n0.02%\n1Y\n44.1%\nZhejiang Meorient Commerce Exhibition\nMarket Cap: CN\u00a54.6b\nZhejiang Meorient Commerce Exhibition Inc.\n300795\nCN\u00a515.51\n7D\n0.06%\n1Y\n34.9%\nUgreen Group\nMarket Cap: CN\u00a524.5b\nEngages in the research, development, design, production, and sale of consumer electronic products in China and internationally.\n301606\nCN\u00a559.00\n7D\n17.7%\n1Y\n95.6%\nBlinkLab\nMarket Cap: AU$55.1m\nFocuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing.\nBB1\nAU$0.44\n7D\n3.5%\n1Y\n104.7%\nShelly Group\nMarket Cap: \u20ac908.9m\nEngages in development, production, and sale of internet of things devices.\nSLYG\n\u20ac50.20\n7D\n3.1%\n1Y\n37.2%\nargenx\nMarket Cap: \u20ac33.9b\nA commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.\nARGX\n\u20ac553.20\n7D\n-5.9%\n1Y\n13.2%\nT&S CommunicationsLtd\nMarket Cap: CN\u00a527.1b\nDevelops, manufactures, and sells fiber optics communication products in China.\n300570\nCN\u00a5121.98\n7D\n6.2%\n1Y\n316.0%\nDEAR U\nMarket Cap: \u20a91.3t\nDear U Co., Ltd. operates as an information technology company.\nA376300\n\u20a953,700.00\n7D\n13.1%\n1Y\n153.3%\nXiamen Amoytop Biotech\nMarket Cap: CN\u00a535.1b\nEngages in research, development, production, and sale of recombinant protein drugs in China.\n688278\nCN\u00a586.40\n7D\n-3.5%\n1Y\n62.3%\nDongHua Testing Technology\nMarket Cap: CN\u00a55.7b\nProvides structural mechanical properties in China.\n300354\nCN\u00a541.39\n7D\n2.9%\n1Y\n31.4%\nMereo BioPharma Group\nMarket Cap: US$243.3m\nA biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.\nMREO\nUS$1.52\n7D\n-8.4%\n1Y\n-59.1%\nNewborn Town\nMarket Cap: HK$14.6b\nAn investment holding company, engages in the social networking business worldwide.\n9911\nHK$10.85\n7D\n7.4%\n1Y\n255.7%\nAsia Vital Components\nMarket Cap: NT$419.2b\nProvides thermal solutions worldwide.\n3017\nNT$1,080.00\n7D\n15.6%\n1Y\n84.6%\nPalantir Technologies\nMarket Cap: US$443.5b\nPalantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.\nPLTR\nUS$182.68\n7D\n13.7%\n1Y\n521.8%\nMedical Data Vision\nMarket Cap: JP\u00a520.1b\nDevelops, produces, maintains, and sells medical information integration systems in Japan.\n3902\nJP\u00a5531.00\n7D\n5.6%\n1Y\n16.7%\nUnicomp Technology Group\nMarket Cap: CN\u00a59.9b\nEngages in the research, development, manufacture, and sale of X-ray technology and intelligent detection equipment in China.\n688531\nCN\u00a560.38\n7D\n10.4%\n1Y\n128.1%"
    },
    {
      "url": "https://simplywall.st/company/id/51111a05-86d2-493b-bae2-9c04f7524ca4/past?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=3982594",
      "text": "Beijing Labtech Instruments Past Earnings Performance\nPast criteria checks 4/6\nBeijing Labtech Instruments's earnings have been declining at an average annual rate of -15.6%, while the Electronic industry saw earnings growing at 0.4% annually. Revenues have been growing at an average rate of 4.2% per year. Beijing Labtech Instruments's return on equity is 4.9%, and it has net margins of 9.7%.\nKey information\n-15.59%\nEarnings growth rate\n-20.69%\nEPS growth rate\n| Electronic Industry Growth | 10.93% |\n| Revenue growth rate | 4.21% |\n| Return on equity | 4.86% |\n| Net Margin | 9.66% |\n| Next Earnings Update | 29 Aug 2025 |\nRecent past performance updates\nRecent updates\nWhy Investors Shouldn't Be Surprised By Beijing Labtech Instruments Co., Ltd.'s (SHSE:688056) 41% Share Price Surge\nOct 09Beijing Labtech Instruments' (SHSE:688056) Soft Earnings Are Actually Better Than They Appear\nMay 02Beijing Labtech Instruments Co., Ltd. (SHSE:688056) Looks Just Right With A 29% Price Jump\nMar 08Revenue & Expenses Breakdown\nHow Beijing Labtech Instruments makes and spends money. Based on latest reported earnings, on an LTM basis.\nEarnings and Revenue History\n| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |\n|---|---|---|---|---|\n| 31 Mar 25 | 418 | 40 | 97 | 50 |\n| 31 Dec 24 | 424 | 39 | 99 | 51 |\n| 30 Sep 24 | 427 | 36 | 101 | 53 |\n| 30 Jun 24 | 434 | 29 | 103 | 55 |\n| 31 Mar 24 | 425 | 26 | 103 | 55 |\n| 31 Dec 23 | 416 | 28 | 103 | 52 |\n| 30 Sep 23 | 406 | 37 | 100 | 48 |\n| 30 Jun 23 | 396 | 45 | 96 | 43 |\n| 31 Mar 23 | 374 | 46 | 91 | 40 |\n| 31 Dec 22 | 355 | 45 | 86 | 38 |\n| 30 Sep 22 | 349 | 51 | 83 | 35 |\n| 30 Jun 22 | 342 | 57 | 79 | 34 |\n| 31 Mar 22 | 367 | 67 | 79 | 33 |\n| 31 Dec 21 | 369 | 69 | 77 | 31 |\n| 30 Sep 21 | 392 | 82 | 79 | 33 |\n| 30 Jun 21 | 392 | 80 | 78 | 31 |\n| 31 Mar 21 | 383 | 80 | 73 | 31 |\n| 31 Dec 20 | 349 | 65 | 71 | 29 |\n| 30 Sep 20 | 353 | 58 | 67 | 29 |\n| 30 Jun 20 | 353 | 55 | 70 | 29 |\n| 31 Mar 20 | 342 | 48 | 73 | 28 |\n| 31 Dec 19 | 381 | 61 | 77 | 26 |\n| 31 Dec 18 | 350 | 60 | 84 | 13 |\n| 31 Dec 17 | 322 | 49 | 84 | 14 |\n| 31 Dec 14 | 218 | 29 | 70 | 0 |\nQuality Earnings: 688056 has high quality earnings.\nGrowing Profit Margin: 688056's current net profit margins (9.7%) are higher than last year (6.2%).\nFree Cash Flow vs Earnings Analysis\nPast Earnings Growth Analysis\nEarnings Trend: 688056's earnings have declined by 15.6% per year over the past 5 years.\nAccelerating Growth: 688056's earnings growth over the past year (53.6%) exceeds its 5-year average (-15.6% per year).\nEarnings vs Industry: 688056 earnings growth over the past year (53.6%) exceeded the Electronic industry 2.8%.\nReturn on Equity\nHigh ROE: 688056's Return on Equity (4.9%) is considered low.\nReturn on Assets\nReturn on Capital Employed\nDiscover strong past performing companies\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/11 22:44 |\n| End of Day Share Price | 2025/08/11 00:00 |\n| Earnings | 2025/03/31 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nBeijing Labtech Instruments Co., Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| Zhongshu Yin | Everbright Securities Co. Ltd. |"
    },
    {
      "url": "https://simplywall.st/company/id/a19b6937-cbb0-46bd-81fc-c3064ac9b509/past?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=3982594",
      "text": "WuXi Xinje ElectricLtd Past Earnings Performance\nPast criteria checks 2/6\nWuXi Xinje ElectricLtd's earnings have been declining at an average annual rate of -7.7%, while the Electronic industry saw earnings growing at 0.4% annually. Revenues have been growing at an average rate of 11.8% per year. WuXi Xinje ElectricLtd's return on equity is 9.8%, and it has net margins of 13.1%.\nKey information\n-7.74%\nEarnings growth rate\n-7.60%\nEPS growth rate\n| Electronic Industry Growth | 10.93% |\n| Revenue growth rate | 11.77% |\n| Return on equity | 9.81% |\n| Net Margin | 13.10% |\n| Next Earnings Update | 28 Aug 2025 |\nRecent past performance updates\nRecent updates\nUnpleasant Surprises Could Be In Store For WuXi Xinje Electric Co.,Ltd.'s (SHSE:603416) Shares\nMar 12WuXi Xinje ElectricLtd (SHSE:603416) Could Easily Take On More Debt\nFeb 24Estimating The Intrinsic Value Of WuXi Xinje Electric Co.,Ltd. (SHSE:603416)\nJan 24Investors Could Be Concerned With WuXi Xinje ElectricLtd's (SHSE:603416) Returns On Capital\nJan 03WuXi Xinje Electric Co.,Ltd.'s (SHSE:603416) Low P/E No Reason For Excitement\nOct 16Is WuXi Xinje ElectricLtd (SHSE:603416) Using Too Much Debt?\nSep 30WuXi Xinje Electric Co.,Ltd.'s (SHSE:603416) Share Price Is Matching Sentiment Around Its Earnings\nJun 26WuXi Xinje ElectricLtd (SHSE:603416) Has A Rock Solid Balance Sheet\nMay 28WuXi Xinje ElectricLtd's (SHSE:603416) Conservative Accounting Might Explain Soft Earnings\nApr 26The Returns On Capital At WuXi Xinje ElectricLtd (SHSE:603416) Don't Inspire Confidence\nMar 28There's No Escaping WuXi Xinje Electric Co.,Ltd.'s (SHSE:603416) Muted Earnings Despite A 33% Share Price Rise\nMar 06WuXi Xinje ElectricLtd (SHSE:603416) Seems To Use Debt Quite Sensibly\nFeb 28Revenue & Expenses Breakdown\nHow WuXi Xinje ElectricLtd makes and spends money. Based on latest reported earnings, on an LTM basis.\nEarnings and Revenue History\n| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |\n|---|---|---|---|---|\n| 31 Mar 25 | 1,757 | 230 | 306 | 168 |\n| 31 Dec 24 | 1,708 | 229 | 289 | 168 |\n| 30 Sep 24 | 1,634 | 219 | 260 | 164 |\n| 30 Jun 24 | 1,584 | 222 | 240 | 159 |\n| 31 Mar 24 | 1,516 | 203 | 221 | 149 |\n| 31 Dec 23 | 1,505 | 199 | 211 | 147 |\n| 30 Sep 23 | 1,411 | 194 | 201 | 133 |\n| 30 Jun 23 | 1,376 | 190 | 190 | 125 |\n| 31 Mar 23 | 1,343 | 188 | 187 | 124 |\n| 31 Dec 22 | 1,335 | 222 | 176 | 120 |\n| 30 Sep 22 | 1,335 | 256 | 159 | 120 |\n| 30 Jun 22 | 1,343 | 284 | 153 | 116 |\n| 31 Mar 22 | 1,312 | 290 | 140 | 112 |\n| 31 Dec 21 | 1,299 | 304 | 127 | 108 |\n| 30 Sep 21 | 1,294 | 315 | 112 | 97 |\n| 30 Jun 21 | 1,271 | 344 | 93 | 90 |\n| 31 Mar 21 | 1,278 | 373 | 90 | 88 |\n| 31 Dec 20 | 1,134 | 332 | 81 | 77 |\n| 30 Sep 20 | 996 | 294 | 78 | 74 |\n| 30 Jun 20 | 841 | 235 | 77 | 68 |\n| 31 Mar 20 | 681 | 179 | 63 | 57 |\n| 31 Dec 19 | 650 | 163 | 64 | 55 |\n| 30 Sep 19 | 619 | 159 | 62 | 51 |\n| 30 Jun 19 | 614 | 153 | 59 | 50 |\n| 31 Mar 19 | 608 | 152 | 55 | 47 |\n| 31 Dec 18 | 590 | 149 | 52 | 45 |\n| 30 Sep 18 | 580 | 131 | 51 | 47 |\n| 30 Jun 18 | 544 | 127 | 31 | 60 |\n| 31 Mar 18 | 510 | 126 | 38 | 50 |\n| 31 Dec 17 | 484 | 124 | 44 | 41 |\n| 30 Sep 17 | 446 | 134 | 47 | 26 |\n| 30 Jun 17 | 417 | 122 | 68 | 0 |\n| 31 Mar 17 | 379 | 107 | 65 | 0 |\n| 31 Dec 16 | 353 | 100 | 60 | 0 |\n| 30 Sep 16 | 330 | 90 | 96 | 0 |\n| 31 Dec 15 | 303 | 81 | 53 | 0 |\n| 31 Dec 14 | 294 | 76 | 48 | 0 |\nQuality Earnings: 603416 has a large one-off gain of CN\u00a564.9M impacting its last 12 months of financial results to 31st March, 2025.\nGrowing Profit Margin: 603416's current net profit margins (13.1%) are lower than last year (13.4%).\nFree Cash Flow vs Earnings Analysis\nPast Earnings Growth Analysis\nEarnings Trend: 603416's earnings have declined by 7.7% per year over the past 5 years.\nAccelerating Growth: 603416's earnings growth over the past year (13.6%) exceeds its 5-year average (-7.7% per year).\nEarnings vs Industry: 603416 earnings growth over the past year (13.6%) exceeded the Electronic industry 2.8%.\nReturn on Equity\nHigh ROE: 603416's Return on Equity (9.8%) is considered low.\nReturn on Assets\nReturn on Capital Employed\nDiscover strong past performing companies\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/11 02:32 |\n| End of Day Share Price | 2025/08/11 00:00 |\n| Earnings | 2025/03/31 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nWuXi Xinje Electric Co.,Ltd. is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| Peng Jiang | China International Capital Corporation Limited |\n| Zishuo Li | Citic Securities Co., Ltd. |\n| Xiang Huang | Credit Suisse |"
    },
    {
      "url": "https://simplywall.st/company/id/6728b25c-0acb-4f2f-853f-a44304ab62c8/past?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=3982594",
      "text": "Essex Bio-Technology Past Earnings Performance\nPast criteria checks 4/6\nEssex Bio-Technology has been growing earnings at an average annual rate of 0.6%, while the Biotechs industry saw earnings growing at 39.6% annually. Revenues have been growing at an average rate of 8.9% per year. Essex Bio-Technology's return on equity is 14.5%, and it has net margins of 18.4%.\nKey information\n0.57%\nEarnings growth rate\n0.99%\nEPS growth rate\n| Biotechs Industry Growth | 11.00% |\n| Revenue growth rate | 8.86% |\n| Return on equity | 14.47% |\n| Net Margin | 18.40% |\n| Last Earnings Update | 31 Dec 2024 |\nRecent past performance updates\nRecent updates\nMost Shareholders Will Probably Find That The Compensation For Essex Bio-Technology Limited's (HKG:1061) CEO Is Reasonable\nMay 14A Look At The Fair Value Of Essex Bio-Technology Limited (HKG:1061)\nApr 29Essex Bio-Technology Limited (HKG:1061) Stock Catapults 26% Though Its Price And Business Still Lag The Market\nMar 28Essex Bio-Technology Limited (HKG:1061) Surges 29% Yet Its Low P/E Is No Reason For Excitement\nOct 09Essex Bio-Technology's (HKG:1061) Upcoming Dividend Will Be Larger Than Last Year's\nAug 29Essex Bio-Technology Limited's (HKG:1061) Low P/E No Reason For Excitement\nMay 06Calculating The Fair Value Of Essex Bio-Technology Limited (HKG:1061)\nMar 21Essex Bio-Technology (HKG:1061) Has A Pretty Healthy Balance Sheet\nDec 07Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly\nDec 07Essex Bio-Technology (HKG:1061) Is Due To Pay A Dividend Of HK$0.04\nAug 25Is Essex Bio-Technology (HKG:1061) Using Too Much Debt?\nJun 22Essex Bio-Technology (HKG:1061) Has Announced That It Will Be Increasing Its Dividend To HK$0.055\nMay 02Essex Bio-Technology (HKG:1061) Will Pay A Larger Dividend Than Last Year At HK$0.055\nMar 30Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly\nJun 29Is Essex Bio-Technology (HKG:1061) A Risky Investment?\nMar 31If You Had Bought Essex Bio-Technology (HKG:1061) Stock Five Years Ago, You Could Pocket A 40% Gain Today\nMar 13How Many Essex Bio-Technology Limited (HKG:1061) Shares Did Insiders Buy, In The Last Year?\nFeb 15Do Institutions Own Essex Bio-Technology Limited (HKG:1061) Shares?\nJan 25Essex Bio-Technology Limited's (HKG:1061) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?\nJan 04Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly\nDec 13Why Essex Bio-Technology's (HKG:1061) CEO Pay Matters\nNov 23Revenue & Expenses Breakdown\nHow Essex Bio-Technology makes and spends money. Based on latest reported earnings, on an LTM basis.\nEarnings and Revenue History\n| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |\n|---|---|---|---|---|\n| 31 Dec 24 | 1,670 | 307 | 1,148 | 0 |\n| 30 Sep 24 | 1,660 | 285 | 1,154 | 0 |\n| 30 Jun 24 | 1,619 | 263 | 1,160 | 0 |\n| 31 Mar 24 | 1,663 | 269 | 1,195 | 0 |\n| 31 Dec 23 | 1,737 | 275 | 1,229 | 0 |\n| 30 Sep 23 | 1,649 | 266 | 1,161 | 0 |\n| 30 Jun 23 | 1,561 | 256 | 1,093 | 0 |\n| 31 Mar 23 | 1,439 | 241 | 1,003 | 0 |\n| 31 Dec 22 | 1,318 | 225 | 914 | 0 |\n| 30 Sep 22 | 1,437 | 274 | 950 | 0 |\n| 30 Jun 22 | 1,556 | 323 | 987 | 0 |\n| 31 Mar 22 | 1,597 | 334 | 988 | 0 |\n| 31 Dec 21 | 1,638 | 346 | 990 | 0 |\n| 30 Sep 21 | 1,515 | 339 | 908 | 0 |\n| 30 Jun 21 | 1,392 | 332 | 825 | 0 |\n| 31 Mar 21 | 1,185 | 275 | 707 | 0 |\n| 31 Dec 20 | 978 | 219 | 588 | 0 |\n| 30 Sep 20 | 1,000 | 221 | 589 | 0 |\n| 30 Jun 20 | 1,022 | 222 | 589 | 0 |\n| 31 Mar 20 | 1,151 | 262 | 652 | 0 |\n| 31 Dec 19 | 1,279 | 303 | 715 | 0 |\n| 30 Sep 19 | 1,238 | 282 | 715 | 0 |\n| 30 Jun 19 | 1,197 | 262 | 716 | 0 |\n| 31 Mar 19 | 1,187 | 246 | 717 | 0 |\n| 31 Dec 18 | 1,176 | 231 | 719 | 0 |\n| 30 Sep 18 | 1,100 | 210 | 673 | 0 |\n| 30 Jun 18 | 1,023 | 189 | 628 | 0 |\n| 31 Mar 18 | 961 | 178 | 592 | 0 |\n| 31 Dec 17 | 900 | 167 | 556 | 0 |\n| 30 Sep 17 | 874 | 159 | 528 | 0 |\n| 30 Jun 17 | 849 | 151 | 500 | 0 |\n| 31 Mar 17 | 813 | 144 | 479 | 0 |\n| 31 Dec 16 | 776 | 136 | 458 | 0 |\n| 30 Sep 16 | 740 | 126 | 446 | 0 |\n| 30 Jun 16 | 705 | 115 | 434 | 0 |\n| 31 Mar 16 | 679 | 110 | 419 | 0 |\n| 31 Dec 15 | 654 | 105 | 403 | 0 |\n| 30 Sep 15 | 627 | 101 | 379 | 0 |\n| 30 Jun 15 | 600 | 96 | 355 | 0 |\n| 31 Mar 15 | 559 | 86 | 334 | 0 |\n| 31 Dec 14 | 518 | 75 | 314 | 0 |\n| 30 Sep 14 | 466 | 67 | 295 | 0 |\nQuality Earnings: 1061 has high quality earnings.\nGrowing Profit Margin: 1061's current net profit margins (18.4%) are higher than last year (15.8%).\nFree Cash Flow vs Earnings Analysis\nPast Earnings Growth Analysis\nEarnings Trend: 1061's earnings have grown by 0.6% per year over the past 5 years.\nAccelerating Growth: 1061's earnings growth over the past year (11.6%) exceeds its 5-year average (0.6% per year).\nEarnings vs Industry: 1061 earnings growth over the past year (11.6%) did not outperform the Biotechs industry 15.7%.\nReturn on Equity\nHigh ROE: 1061's Return on Equity (14.5%) is considered low.\nReturn on Assets\nReturn on Capital Employed\nDiscover strong past performing companies\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/11 00:49 |\n| End of Day Share Price | 2025/08/11 00:00 |\n| Earnings | 2024/12/31 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nEssex Bio-Technology Limited is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| Xiao Wei Lin | Everbright Securities Co. Ltd. |\n| null null | Guoyuan Securities (HK) Ltd |\n| Stella Xing | Nomura Securities Co. Ltd. |"
    },
    {
      "url": "https://simplywall.st/discover/investing-ideas/10228/fast-growing-stocks-with-high-insider-ownership/global?utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo&blueprint=3982594",
      "text": "Results\n1357\nCompanies with strong growth potential, backed by optimistic outlooks both from analysts and management.\n1357 companies\nGold Circuit Electronics\nMarket Cap: NT$214.4b\nDesigns, manufactures, processes, and distributes printed circuit boards in Taiwan.\n2368\nNT$440.50\n7D\n21.7%\n1Y\n112.8%\nCyclopharm\nMarket Cap: AU$103.4m\nCyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally.\nCYC\nAU$0.93\n7D\n-5.1%\n1Y\n-34.3%\nFulin Precision\nMarket Cap: CN\u00a524.5b\nEngages in the research and development, manufacture, and sale of automotive engine parts in China.\n300432\nCN\u00a514.32\n7D\n12.4%\n1Y\n232.5%\nFindi\nMarket Cap: AU$225.6m\nThrough its subsidiaries, engages in the development of digital payment systems in India.\nFND\nAU$3.65\n7D\n-1.1%\n1Y\n2.0%\nNovoray\nMarket Cap: CN\u00a513.1b\nProvides industrial powder materials for various applications in China and internationally.\n688300\nCN\u00a554.10\n7D\n-1.7%\n1Y\n61.9%\nShanghai Huace Navigation Technology\nMarket Cap: CN\u00a528.9b\nShanghai Huace Navigation Technology Ltd.\n300627\nCN\u00a537.02\n7D\n2.6%\n1Y\n81.4%\nLaopu Gold\nMarket Cap: HK$131.0b\nDesigns, manufactures, and sells jewelry products in Mainland China, Hong Kong, and Macau.\n6181\nHK$758.50\n7D\n3.5%\n1Y\n820.5%\nPharma Mar\nMarket Cap: \u20ac1.4b\nA biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.\nPHM\n\u20ac77.80\n7D\n-2.0%\n1Y\n117.7%\nCD Projekt\nMarket Cap: z\u014225.6b\nTogether its subsidiaries, engages in the development, publishing, and digital distribution of video games for personal computers and video game consoles in Poland.\nCDR\nz\u0142255.80\n7D\n3.4%\n1Y\n50.1%\nElliptic Laboratories\nMarket Cap: NOK 1.3b\nAn artificial intelligence (AI) software company, engages in the provision of AI virtual smart sensors for the smartphone, laptop, Internet of Things, and automotive markets in Norway, the United States, China, South Korea, Taiwan, and Japan.\nELABS\nNOK 12.02\n7D\n1.3%\n1Y\n14.0%\nCredo Technology Group Holding\nMarket Cap: US$20.7b\nProvides various high-speed connectivity solutions for optical and electrical Ethernet, and PCIe applications in the United States, Taiwan, Mainland China, Hong Kong, and internationally.\nCRDO\nUS$118.57\n7D\n3.4%\n1Y\n329.6%\nPropel Holdings\nMarket Cap: CA$1.4b\nOperates as a financial technology company.\nPRL\nCA$34.52\n7D\n-0.4%\n1Y\n36.8%\nKebNi\nMarket Cap: SEK 599.3m\nDevelops, produces, and sells products and applications for stabilization, navigation, and satcom worldwide.\nKEBNI B\nSEK 2.21\n7D\n-7.9%\n1Y\n51.8%\nNewfield Resources\nMarket Cap: AU$83.7m\nEngages in the mine development, stope mining, and mineral exploration activities in Australia and Africa.\nNWF\nAU$0.089\n7D\n0%\n1Y\n-19.1%\nKrishna Institute of Medical Sciences\nMarket Cap: \u20b9290.7b\nProvides medical and health care services under the KIMS Hospitals brand in India.\nKIMS\n\u20b9726.50\n7D\n-2.8%\n1Y\n61.8%\nZhejiang Leapmotor Technology\nMarket Cap: HK$85.4b\nEngages in the research and development, production, and sale of new energy vehicles in Mainland China and internationally.\n9863\nHK$63.90\n7D\n0.6%\n1Y\n178.4%\nAnand Rathi Wealth\nMarket Cap: \u20b9223.6b\nProvides financial advisory, brokerage, and consultancy services in India.\nANANDRATHI\n\u20b92,693.60\n7D\n1.7%\n1Y\n47.4%\nOscotec\nMarket Cap: \u20a91.2t\nOperates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.\nA039200\n\u20a931,250.00\n7D\n1.6%\n1Y\n-20.0%\nBinastra Corporation Berhad\nMarket Cap: RM 1.9b\nAn investment holding company, engages in general contractor and property developer, building and civil engineering works in turnkey projects in Malaysia.\nBNASTRA\nRM 1.76\n7D\n-1.7%\n1Y\n44.3%\nFenix Resources\nMarket Cap: AU$226.0m\nEngages in the exploration, development, and mining of mineral tenements in Western Australia.\nFEX\nAU$0.30\n7D\n-3.2%\n1Y\n-17.6%\nM31 Technology\nMarket Cap: NT$20.9b\nProvides silicon intellectual property (IP) design services in the integrated circuit industry.\n6643\nNT$499.00\n7D\n-0.8%\n1Y\n-42.0%\nVuno\nMarket Cap: \u20a9269.5b\nOperates as a medical artificial intelligence (AI) solution development company.\nA338220\n\u20a919,250.00\n7D\n0.4%\n1Y\n-42.5%\nImage Resources\nMarket Cap: AU$88.1m\nEngages in the production and exploration of mineral sands in Western Australia.\nIMA\nAU$0.079\n7D\n-1.3%\n1Y\n14.5%\nSuzhou Sunmun Technology\nMarket Cap: CN\u00a54.7b\nEngages in the research, production, and sale of nano-coloring materials, functional nano-dispersions, special additives, intelligent color matching systems, and electronic chemicals in China.\n300522\nCN\u00a514.43\n7D\n-2.2%\n1Y\n54.0%\nAlfabs Australia\nMarket Cap: AU$111.8m\nEngages in the mining equipment and engineering business in Australia.\nAAL\nAU$0.39\n7D\n-2.5%\n1Y\n56.0%\nTechwing\nMarket Cap: \u20a91.0t\nDevelops, manufactures, sells, and services semiconductor inspection equipment in South Korea and internationally.\nA089030\n\u20a929,200.00\n7D\n8.3%\n1Y\n-31.8%\nSamyang Foods\nMarket Cap: \u20a911.2t\nEngages in the food business in South Korea and internationally.\nA003230\n\u20a91,502,000.00\n7D\n7.7%\n1Y\n155.9%\nSineng ElectricLtd\nMarket Cap: CN\u00a512.1b\nEngages in the research and development, manufacture, maintenance, and trading of power electronic products in the People's Republic of China and internationally.\n300827\nCN\u00a524.10\n7D\n5.1%\n1Y\n8.4%\nMarinomed Biotech\nMarket Cap: \u20ac36.5m\nA biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally.\nMARI\n\u20ac20.50\n7D\n-1.9%\n1Y\n105.0%\nHippo Holdings\nMarket Cap: US$721.6m\nProvides property and casualty insurance products to individuals and business customers primarily in the United States.\nHIPO\nUS$28.91\n7D\n8.5%\n1Y\n61.0%\nENGAGE XR Holdings\nMarket Cap: UK\u00a35.4m\nEngages in the development of the educational virtual reality platform.\nEXR\nUK\u00a30.01\n7D\n0%\n1Y\n17.1%\nCircus\nMarket Cap: \u20ac356.8m\nA technology company, develops and delivers autonomous solutions for the food service market.\nCA1\n\u20ac15.00\n7D\n3.1%\n1Y\n-24.2%\nBergen Carbon Solutions\nMarket Cap: NOK 195.2m\nOperates as a clean carbon technology and materials company in Norway.\nBCS\nNOK 4.65\n7D\n-10.2%\n1Y\n-41.1%\nAtour Lifestyle Holdings\nMarket Cap: US$4.9b\nThrough its subsidiaries, develops lifestyle brands around hotel offerings in the People\u2019s Republic of China.\nATAT\nUS$34.96\n7D\n1.0%\n1Y\n105.3%\nFTC Solar\nMarket Cap: US$68.0m\nEngages in the manufacture and service of solar tracker systems in the United States, Asia, Europe, the Middle East, North Africa, South Africa, and Australia.\nFTCI\nUS$4.68\n7D\n-29.2%\n1Y\n122.0%\nHenan Shijia Photons Technology\nMarket Cap: CN\u00a525.1b\nHenan Shijia Photons Technology Co., Ltd.\n688313\nCN\u00a555.45\n7D\n1.6%\n1Y\n538.8%"
    },
    {
      "url": "https://simplywall.st/discover/investing-ideas/152/undiscovered-gems-with-strong-fundamentals/global?utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo&blueprint=3982594",
      "text": "Results\n4716\nHigh-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.\n4716 companies\nAesler Grup Internasional\nMarket Cap: Rp3.7t\nProvides architectural and construction management services in Indonesia.\nRONY\nRp2,990.00\n7D\n0%\n1Y\n1,310.4%\nStandard Bank\nMarket Cap: MK 871.1b\nProvides banking and other related services in Malawi.\nSTANDARD\nMK 3,722.66\n7D\n0.003%\n1Y\n-15.4%\nMaistra d.d\nMarket Cap: \u20ac580.0m\nEngages in the hotel business in Croatia.\nMAIS\n\u20ac53.00\n7D\n0%\n1Y\n24.4%\nChudenko\nMarket Cap: JP\u00a5209.6b\nOperates as an equipment engineering company in Japan.\n1941\nJP\u00a53,870.00\n7D\n4.0%\n1Y\n26.5%\nCapricorn Group\nMarket Cap: R11.2b\nAn investment holding company, engages in the banking, microlending, and related businesses in Namibia, Botswana, and Zambia.\nCGP\nR22.02\n7D\n1.0%\n1Y\n13.2%\nSaison Technology\nMarket Cap: JP\u00a531.6b\nEngages in the system development and operation, and software package businesses in Japan.\n9640\nJP\u00a51,952.00\n7D\n1.0%\n1Y\n8.4%\nKurimotoLtd\nMarket Cap: JP\u00a588.5b\nManufactures and sells ductile iron pipes and accessories, valves, industrial equipment and materials, and construction materials in Japan and internationally.\n5602\nJP\u00a57,300.00\n7D\n-7.5%\n1Y\n81.4%\nNARUMIYA INTERNATIONAL\nMarket Cap: JP\u00a516.0b\nManufactures, processes, and sells clothing and related products.\n9275\nJP\u00a51,627.00\n7D\n2.8%\n1Y\n33.1%\nFALCO HOLDINGS\nMarket Cap: JP\u00a525.0b\nA medical service company, provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan.\n4671\nJP\u00a52,520.00\n7D\n3.8%\n1Y\n11.6%\nGB Holdings\nMarket Cap: US$54.2m\nProvides rubber and chemical products in Zimbabwe.\nGBH\nUS$0.10\n7D\n0.3%\n1Y\n66.7%\nISE Chemicals\nMarket Cap: JP\u00a5145.4b\nEngages in the iodine and natural gas, and metallic compound businesses in Japan.\n4107\nJP\u00a528,530.00\n7D\n4.1%\n1Y\n51.0%\nCHANGE HoldingsInc\nMarket Cap: JP\u00a580.9b\nProvides IT human resources development training services in Japan.\n3962\nJP\u00a51,163.00\n7D\n0.2%\n1Y\n15.4%\nZambia Sugar\nMarket Cap: K13.3b\nEngages in growing of sugar cane in Zambia, the Democratic Republic of Congo, Kenya, and South Africa.\nZSUG\nK41.86\n7D\n0%\n1Y\n19.6%\nMorris State Bancshares\nMarket Cap: US$255.6m\nOperates as the bank holding company for Morris Bank that provides various financial services to individuals and small businesses in Georgia.\nMBLU\nUS$24.00\n7D\n-2.0%\n1Y\n42.0%\nEbara JitsugyoLtd\nMarket Cap: JP\u00a550.6b\nManufactures and sells environment related products in Japan.\n6328\nJP\u00a54,250.00\n7D\n10.5%\n1Y\n20.2%\nFCE\nMarket Cap: JP\u00a519.0b\nThrough its subsidiaries, engages in the DX promotion, education and training, and publishing businesses in Japan.\n9564\nJP\u00a5864.00\n7D\n1.9%\n1Y\n103.8%\nOUG Holdings\nMarket Cap: JP\u00a521.0b\nThrough its subsidiaries, engages in the wholesale of marine products in Japan.\n8041\nJP\u00a53,890.00\n7D\n3.0%\n1Y\n53.6%\nShimizu Bank\nMarket Cap: JP\u00a519.1b\nProvides various banking services in Japan.\n8364\nJP\u00a51,700.00\n7D\n2.5%\n1Y\n14.2%\nSystem ResearchLtd\nMarket Cap: JP\u00a534.8b\nOffers software development services in Japan.\n3771\nJP\u00a52,100.00\n7D\n-3.0%\n1Y\n53.6%\nE J Holdings\nMarket Cap: JP\u00a528.8b\nThrough its subsidiaries, engages in the civil engineering consultant business in Japan and internationally.\n2153\nJP\u00a51,833.00\n7D\n1.4%\n1Y\n11.5%\nYashima Denki\nMarket Cap: JP\u00a544.3b\nProvides plant business, industry/equipment, and transportation business in Japan and internationally.\n3153\nJP\u00a52,081.00\n7D\n12.5%\n1Y\n39.4%\nOhashi Technica\nMarket Cap: JP\u00a529.8b\nDevelops, manufactures, and sells automotive parts and other components in Japan, the United States, Mexico, Thailand, Taiwan, China, and Europe.\n7628\nJP\u00a52,328.00\n7D\n4.6%\n1Y\n39.2%\nAraya Industrial\nMarket Cap: JP\u00a524.2b\nManufactures and sells steel products in Japan and internationally.\n7305\nJP\u00a55,070.00\n7D\n1.2%\n1Y\n4.5%\nYagiLtd\nMarket Cap: JP\u00a527.5b\nOperates as a fiber trading company in Japan.\n7460\nJP\u00a53,280.00\n7D\n8.8%\n1Y\n66.9%\nOpenWork\nMarket Cap: JP\u00a523.9b\nDevelops and manages a job and recruitment information platform in Japan.\n5139\nJP\u00a51,119.00\n7D\n9.3%\n1Y\n149.8%\nNice\nMarket Cap: JP\u00a522.3b\nImports, distributes, and sells building materials for housing in Japan and internationally.\n8089\nJP\u00a51,880.00\n7D\n1.6%\n1Y\n-1.1%\nUoriki\nMarket Cap: JP\u00a534.8b\nEngages in the retail, food and beverage, and wholesale businesses in Japan.\n7596\nJP\u00a52,494.00\n7D\n0.3%\n1Y\n4.9%\nGDEP ADVANCEInc\nMarket Cap: JP\u00a517.6b\nEngages in the system incubation business in Japan.\n5885\nJP\u00a53,255.00\n7D\n-3.4%\n1Y\n60.0%\nTokyo Tekko\nMarket Cap: JP\u00a549.4b\nEngages in the manufacture and sale of steel bars and processed steel bar products for the construction industry in Japan.\n5445\nJP\u00a55,800.00\n7D\n3.9%\n1Y\n27.2%\nKanro\nMarket Cap: JP\u00a585.4b\nManufactures and sells confectionery and food products in Japan.\n2216\nJP\u00a52,026.00\n7D\n2.0%\n1Y\n131.1%\nKondotec\nMarket Cap: JP\u00a541.8b\nEngages in the manufacture, procurement, import, sale, wholesale, and export of industrial materials primarily in the retail hardware business in Japan and internationally.\n7438\nJP\u00a51,634.00\n7D\n1.6%\n1Y\n32.2%\nNippon Care Supply\nMarket Cap: JP\u00a532.7b\nEngages in the rental and wholesale of welfare equipment in Japan.\n2393\nJP\u00a52,105.00\n7D\n0.7%\n1Y\n10.6%\nSubaru Enterprise\nMarket Cap: JP\u00a545.3b\nEngages in the maintenance and cleaning of roads and road ancillary facilities in Japan.\n9632\nJP\u00a53,515.00\n7D\n8.2%\n1Y\n25.2%\nKomori\nMarket Cap: JP\u00a580.6b\nEngages in the manufacture, sale, and repair of printing presses in Japan, North America, Europe, and Greater China.\n6349\nJP\u00a51,520.00\n7D\n3.2%\n1Y\n44.5%\nTechno Ryowa\nMarket Cap: JP\u00a599.9b\nEngages in the design, construction, and maintenance of environmental control systems primarily in Japan.\n1965\nJP\u00a54,750.00\n7D\n14.3%\n1Y\n255.8%\nTSTE\nMarket Cap: \u0e3f4.4b\nPrimarily engages in the production and distribution of wheat flour in Thailand.\nTSTE\n\u0e3f11.50\n7D\n-1.7%\n1Y\nn/a"
    },
    {
      "url": "https://simplywall.st/portfolio?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=3982594",
      "text": "US$291,388\nUS$184,224\n19.7%\nUS$126,804\nUS$46,631\nUS$11,515\n-US$726\nUS$4,753\n/yr\nPortfolio\nUS Market\nA past performer with good growth potential\n14 holdings\n14\n| Symbol | Price Vs Fair Value | 7D Return | Total Return | Value & Cost | Weight & Shares | Avg. Price | 1Y chart | |\n|---|---|---|---|---|---|---|---|---|\nPLTR Palantir Technologies | US$182.68 141.5% overvalued intrinsic discount | 13.7% +US$2,202 | 974.6% +US$16,568 | US$18,268 US$1,700 | 6.3% 100 | US$17.00 | ||\nTSLA Tesla | US$339.03 169.9% overvalued intrinsic discount | 9.6% +US$2,977 | 53.4% +US$11,803 | US$33,903 US$22,100 | 11.6% 100 | US$221.00 | ||\nUNH UnitedHealth Group | US$252.37 70.9% undervalued intrinsic discount | 4.7% +US$228 | -37.5% -US$3,360 | US$5,047 US$8,960 | 1.7% 20 | US$448.00 | ||\nAMZN Amazon.com | US$221.30 19.8% undervalued intrinsic discount | 4.6% +US$550 | 59.4% +US$4,928 | US$12,614 US$7,775 | 4.3% 57 | US$136.41 | ||\nBATS British American Tobacco | UK\u00a343.14 31.9% undervalued intrinsic discount | 3.1% +US$1,221 | 43.8% +US$16,878 | US$40,510 US$26,990 | 13.9% 700 | UK\u00a330.00 | ||\nJNJ Johnson & Johnson | US$173.82 28.6% undervalued intrinsic discount | 1.6% +US$139 | 83.4% +US$4,255 | US$8,691 US$5,100 | 3.0% 50 | US$102.00 | ||\nNVDA NVIDIA | US$182.15 58.3% overvalued intrinsic discount | 1.2% +US$86.00 | 879.6% +US$15,263 | US$7,286 US$1,443 | 2.5% 40 | US$36.06 | ||\nBAC Bank of America | US$46.16 24.5% undervalued intrinsic discount | 0.7% +US$186 | 58.2% +US$11,116 | US$27,696 US$19,100 | 9.5% 600 | US$31.83 | ||\nMETA Meta Platforms | US$765.87 27.5% undervalued intrinsic discount | -1.4% -US$893 | 345.1% +US$54,727 | US$65,099 US$13,830 | 22.3% 85 | US$162.71 | ||\nXOM Exxon Mobil | US$105.83 56.7% undervalued intrinsic discount | -1.4% -US$316 | 90.9% +US$11,802 | US$21,695 US$12,897 | 7.4% 205 | US$62.91 | ||\nJPM JPMorgan Chase | US$289.56 16.8% undervalued intrinsic discount | -1.6% -US$235 | 44.4% +US$4,663 | US$14,478 US$10,500 | 5.0% 50 | US$210.00 | ||\nCRWD CrowdStrike Holdings | US$426.43 2.3% undervalued intrinsic discount | -6.3% -US$1,422 | 53.2% +US$9,627 | US$21,322 US$13,100 | 7.3% 50 | US$262.00 | ||\nOKTA Okta | US$88.51 31.6% undervalued intrinsic discount | -9.4% -US$737 | -55.7% -US$8,919 | US$7,081 US$16,000 | 2.4% 80 | US$200.00 | ||\nTLX Telix Pharmaceuticals | AU$16.89 71.6% undervalued intrinsic discount | -16.6% -US$1,527 | 83.1% +US$6,084 | US$7,699 US$5,128 | 2.6% 700 | AU$11.00 |\nThere are three easy ways to get started:\nSimply Wall St goes far beyond price tracking. You'll be able to:\nMost brokers and portfolio trackers only show prices and unrealised gains, with little context and lots of noisy news. Simply Wall St offers:\nIn short, Simply Wall St is more than a tracker \u2014 it's a complete investing platform for monitoring, analysing, and growing your portfolio.\nHave feedback on the portfolio tool?"
    },
    {
      "url": "https://simplywall.st/company/id/51111a05-86d2-493b-bae2-9c04f7524ca4?utm_medium=finance_user&utm_campaign=cta&utm_source=yahoo&blueprint=3982594",
      "text": "Beijing Labtech Instruments (688056) Stock Overview\nManufactures and supplies laboratorial products and solutions to laboratory industry worldwide. More details\n| Snowflake Score | |\n|---|---|\n| Valuation | 1/6 |\n| Future Growth | 5/6 |\n| Past Performance | 4/6 |\n| Financial Health | 6/6 |\n| Dividends | 1/6 |\n688056 Community Fair Values\nSee what others think this stock is worth. Follow their fair value or set your own to get alerts.\nBeijing Labtech Instruments Co., Ltd. Competitors\nPrice History & Performance\n| Historical stock prices | |\n|---|---|\n| Current Share Price | CN\u00a540.00 |\n| 52 Week High | CN\u00a541.27 |\n| 52 Week Low | CN\u00a519.30 |\n| Beta | 0.071 |\n| 1 Month Change | 19.19% |\n| 3 Month Change | 20.16% |\n| 1 Year Change | 95.12% |\n| 3 Year Change | -7.88% |\n| 5 Year Change | n/a |\n| Change since IPO | -15.61% |\nRecent News & Updates\nRecent updates\nWhy Investors Shouldn't Be Surprised By Beijing Labtech Instruments Co., Ltd.'s (SHSE:688056) 41% Share Price Surge\nOct 09Beijing Labtech Instruments' (SHSE:688056) Soft Earnings Are Actually Better Than They Appear\nMay 02Beijing Labtech Instruments Co., Ltd. (SHSE:688056) Looks Just Right With A 29% Price Jump\nMar 08Shareholder Returns\n| 688056 | CN Electronic | CN Market | |\n|---|---|---|---|\n| 7D | 8.7% | 2.6% | 1.9% |\n| 1Y | 95.1% | 54.0% | 34.9% |\nReturn vs Industry: 688056 exceeded the CN Electronic industry which returned 54% over the past year.\nReturn vs Market: 688056 exceeded the CN Market which returned 34.9% over the past year.\nPrice Volatility\n| 688056 volatility | |\n|---|---|\n| 688056 Average Weekly Movement | 4.0% |\n| Electronic Industry Average Movement | 5.1% |\n| Market Average Movement | 4.8% |\n| 10% most volatile stocks in CN Market | 8.4% |\n| 10% least volatile stocks in CN Market | 2.8% |\nStable Share Price: 688056 has not had significant price volatility in the past 3 months compared to the CN market.\nVolatility Over Time: 688056's weekly volatility (4%) has been stable over the past year.\nAbout the Company\n| Founded | Employees | CEO | Website |\n|---|---|---|---|\n| 2002 | 509 | Ke Hu | www.labtechus.com |\nBeijing Labtech Instruments Co., Ltd. manufactures and supplies laboratorial products and solutions to laboratory industry worldwide. It offers water chillers, rotary evaporators, digestion blocks, vacuum pumps, and hot plates; AutoClean GPC cleanup, SepLine solid phase extraction, Sepath solid phase extraction, concentration systems, digestion systems, and evaporation systems; and analytical instruments, including gradient and isocratic HPLC, and UV-Vis spectrophotometers. The company was founded in 2002 and is headquartered in Beijing, China.\nBeijing Labtech Instruments Co., Ltd. Fundamentals Summary\n| 688056 fundamental statistics | |\n|---|---|\n| Market cap | CN\u00a52.67b |\n| Earnings (TTM) | CN\u00a540.34m |\n| Revenue (TTM) | CN\u00a5417.58m |\nIs 688056 overvalued?\nSee Fair Value and valuation analysisEarnings & Revenue\n| 688056 income statement (TTM) | |\n|---|---|\n| Revenue | CN\u00a5417.58m |\n| Cost of Revenue | CN\u00a5227.26m |\n| Gross Profit | CN\u00a5190.32m |\n| Other Expenses | CN\u00a5149.98m |\n| Earnings | CN\u00a540.34m |\nLast Reported Earnings\nMar 31, 2025\nNext Earnings Date\nAug 29, 2025\n| Earnings per share (EPS) | 0.60 |\n| Gross Margin | 45.58% |\n| Net Profit Margin | 9.66% |\n| Debt/Equity Ratio | 0% |\nHow did 688056 perform over the long term?\nSee historical performance and comparisonDividends\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/11 22:44 |\n| End of Day Share Price | 2025/08/11 00:00 |\n| Earnings | 2025/03/31 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nBeijing Labtech Instruments Co., Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| Zhongshu Yin | Everbright Securities Co. Ltd. |"
    },
    {
      "url": "https://simplywall.st/company/id/6728b25c-0acb-4f2f-853f-a44304ab62c8?utm_medium=finance_user&utm_campaign=cta&utm_source=yahoo&blueprint=3982594",
      "text": "Essex Bio-Technology (1061) Stock Overview\nAn investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally. More details\n| Snowflake Score | |\n|---|---|\n| Valuation | 3/6 |\n| Future Growth | 4/6 |\n| Past Performance | 4/6 |\n| Financial Health | 6/6 |\n| Dividends | 3/6 |\nRewards\nRisk Analysis\nNo risks detected for 1061 from our risk checks.\n1061 Community Fair Values\nCreate NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.\nEssex Bio-Technology Limited Competitors\nPrice History & Performance\n| Historical stock prices | |\n|---|---|\n| Current Share Price | HK$5.58 |\n| 52 Week High | HK$5.71 |\n| 52 Week Low | HK$2.15 |\n| Beta | -0.13 |\n| 1 Month Change | 22.91% |\n| 3 Month Change | 27.11% |\n| 1 Year Change | 128.69% |\n| 3 Year Change | 62.21% |\n| 5 Year Change | 10.28% |\n| Change since IPO | 463.64% |\nRecent News & Updates\nRecent updates\nMost Shareholders Will Probably Find That The Compensation For Essex Bio-Technology Limited's (HKG:1061) CEO Is Reasonable\nMay 14A Look At The Fair Value Of Essex Bio-Technology Limited (HKG:1061)\nApr 29Essex Bio-Technology Limited (HKG:1061) Stock Catapults 26% Though Its Price And Business Still Lag The Market\nMar 28Essex Bio-Technology Limited (HKG:1061) Surges 29% Yet Its Low P/E Is No Reason For Excitement\nOct 09Essex Bio-Technology's (HKG:1061) Upcoming Dividend Will Be Larger Than Last Year's\nAug 29Essex Bio-Technology Limited's (HKG:1061) Low P/E No Reason For Excitement\nMay 06Calculating The Fair Value Of Essex Bio-Technology Limited (HKG:1061)\nMar 21Essex Bio-Technology (HKG:1061) Has A Pretty Healthy Balance Sheet\nDec 07Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly\nDec 07Essex Bio-Technology (HKG:1061) Is Due To Pay A Dividend Of HK$0.04\nAug 25Is Essex Bio-Technology (HKG:1061) Using Too Much Debt?\nJun 22Essex Bio-Technology (HKG:1061) Has Announced That It Will Be Increasing Its Dividend To HK$0.055\nMay 02Essex Bio-Technology (HKG:1061) Will Pay A Larger Dividend Than Last Year At HK$0.055\nMar 30Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly\nJun 29Is Essex Bio-Technology (HKG:1061) A Risky Investment?\nMar 31If You Had Bought Essex Bio-Technology (HKG:1061) Stock Five Years Ago, You Could Pocket A 40% Gain Today\nMar 13How Many Essex Bio-Technology Limited (HKG:1061) Shares Did Insiders Buy, In The Last Year?\nFeb 15Do Institutions Own Essex Bio-Technology Limited (HKG:1061) Shares?\nJan 25Essex Bio-Technology Limited's (HKG:1061) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?\nJan 04Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly\nDec 13Why Essex Bio-Technology's (HKG:1061) CEO Pay Matters\nNov 23Shareholder Returns\n| 1061 | HK Biotechs | HK Market | |\n|---|---|---|---|\n| 7D | 7.7% | 4.5% | 2.9% |\n| 1Y | 128.7% | 174.2% | 42.9% |\nReturn vs Industry: 1061 underperformed the Hong Kong Biotechs industry which returned 174.2% over the past year.\nReturn vs Market: 1061 exceeded the Hong Kong Market which returned 42.9% over the past year.\nPrice Volatility\n| 1061 volatility | |\n|---|---|\n| 1061 Average Weekly Movement | 7.6% |\n| Biotechs Industry Average Movement | 10.9% |\n| Market Average Movement | 7.0% |\n| 10% most volatile stocks in HK Market | 15.4% |\n| 10% least volatile stocks in HK Market | 3.4% |\nStable Share Price: 1061 has not had significant price volatility in the past 3 months compared to the Hong Kong market.\nVolatility Over Time: 1061's weekly volatility (8%) has been stable over the past year.\nAbout the Company\n| Founded | Employees | CEO | Website |\n|---|---|---|---|\n| 1990 | 1,450 | Malcolm Ngiam | www.essexbio.com |\nEssex Bio-Technology Limited, an investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally. The company operates through Ophthalmology, Surgical, and Provision of services segments. It researches and develops therapeutic fibroblast growth factor products to treat cellular proliferation, differentiation, and migration.\nEssex Bio-Technology Limited Fundamentals Summary\n| 1061 fundamental statistics | |\n|---|---|\n| Market cap | HK$3.16b |\n| Earnings (TTM) | HK$307.22m |\n| Revenue (TTM) | HK$1.67b |\nIs 1061 overvalued?\nSee Fair Value and valuation analysisEarnings & Revenue\n| 1061 income statement (TTM) | |\n|---|---|\n| Revenue | HK$1.67b |\n| Cost of Revenue | HK$171.15m |\n| Gross Profit | HK$1.50b |\n| Other Expenses | HK$1.19b |\n| Earnings | HK$307.22m |\nLast Reported Earnings\nDec 31, 2024\nNext Earnings Date\nn/a\n| Earnings per share (EPS) | 0.54 |\n| Gross Margin | 89.75% |\n| Net Profit Margin | 18.40% |\n| Debt/Equity Ratio | 7.8% |\nHow did 1061 perform over the long term?\nSee historical performance and comparisonDividends\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/11 00:49 |\n| End of Day Share Price | 2025/08/11 00:00 |\n| Earnings | 2024/12/31 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nEssex Bio-Technology Limited is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| Xiao Wei Lin | Everbright Securities Co. Ltd. |\n| null null | Guoyuan Securities (HK) Ltd |\n| Stella Xing | Nomura Securities Co. Ltd. |"
    },
    {
      "url": "https://simplywall.st/discover/investing-ideas/168/undervalued-stocks-based-on-cash-flows/global?utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo&blueprint=3982594",
      "text": "Results\n834\nCompanies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.\n834 companies\nEcho Investment\nMarket Cap: z\u01422.2b\nEngages in the construction, lease, and sale of office, retail, and residential buildings in Poland.\nECH\nz\u01425.36\n7D\n3.1%\n1Y\n23.5%\nATON Green Storage\nMarket Cap: \u20ac15.4m\nEngages in the production and sale of storage systems for photovoltaic systems and battery energy storage system.\nATON\n\u20ac2.05\n7D\n-5.5%\n1Y\n-60.2%\nAtea\nMarket Cap: NOK 15.8b\nProvides IT infrastructure and related solutions for businesses and public sector organizations in the Nordic countries and Baltic regions.\nATEA\nNOK 141.60\n7D\n1.1%\n1Y\n0.1%\nXi'an NovaStar Tech\nMarket Cap: CN\u00a514.3b\nDesigns and develops light-emitting diode (LED) display control solutions in China and internationally.\n301589\nCN\u00a5156.03\n7D\n0.3%\n1Y\n-3.6%\nTibet Tianlu\nMarket Cap: CN\u00a521.9b\nEngages in general contracting business in China.\n600326\nCN\u00a516.52\n7D\n-5.4%\n1Y\n266.3%\nNanya Technology\nMarket Cap: NT$135.7b\nResearch, develops, manufactures, and sells semiconductor products in Taiwan, Japan, Malaysia, China, the United States, Thailand, Germany, Singapore, Poland and internationally.\n2408\nNT$43.80\n7D\n0.1%\n1Y\n-17.4%\nDigital Workforce Services Oyj\nMarket Cap: \u20ac38.7m\nProvides business process automation services and technology solutions in Finland, Sweden, Norway, Denmark, Poland, rest of the European Union, and internationally.\nDWF\n\u20ac3.46\n7D\n-0.9%\n1Y\n-16.4%\nUdemy\nMarket Cap: US$1.1b\nA learning company, that operates a marketplace platform for learning skills in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.\nUDMY\nUS$6.65\n7D\n-10.5%\n1Y\n-4.9%\nUWC Berhad\nMarket Cap: RM 3.0b\nAn investment holding company, engages in the provision of precision sheet metal fabrication, precision machined components, and value-added assembly services.\nUWC\nRM 2.70\n7D\n8.9%\n1Y\n-3.9%\nSparebank 68\u00b0 Nord\nMarket Cap: NOK 530.7m\nOperates as a savings bank that provides a range of banking services to personal and corporate market in Norway.\nSB68\nNOK 178.50\n7D\n1.1%\n1Y\n11.6%\nams-OSRAM\nMarket Cap: CHF 1.0b\nEngages in the design, manufacture, and sale of LED and optical sensor solutions in Europe, the Middle East, Africa, the Americas, and the Asia/Pacific.\nAMS\nCHF 10.52\n7D\n-0.5%\n1Y\n5.1%\nExel Composites Oyj\nMarket Cap: \u20ac40.6m\nManufactures and sells composite profiles and tubes made with pultrusion, pull-winding, and continuous lamination processes in Europe, North America, the Asia Pacific, and internationally.\nEXL1V\n\u20ac0.38\n7D\n0.5%\n1Y\n32.1%\nHeartland Group Holdings\nMarket Cap: NZ$752.1m\nProvides various financial services in New Zealand and Australia.\nHGH\nNZ$0.80\n7D\n0%\n1Y\n-24.5%\nRange Intelligent Computing Technology Group\nMarket Cap: CN\u00a581.7b\nProvides server hosting services to internet companies and large cloud vendors in China.\n300442\nCN\u00a549.99\n7D\n2.3%\n1Y\n137.5%\nPetroVietnam Power Corporation - JSC\nMarket Cap: \u20ab35.4t\nEngages in the production and distribution of industrial and consumer electricity in Vietnam.\nPOW\n\u20ab15,100.00\n7D\n2.4%\n1Y\n11.0%\ncyan\nMarket Cap: \u20ac44.8m\nThrough its subsidiaries, provides cybersecurity solutions and telecommunication services in Europe, the Middle East, Africa, and the Asia-Pacific.\nCYR\n\u20ac2.22\n7D\n-3.5%\n1Y\n-4.3%\nAndes Technology\nMarket Cap: NT$13.9b\nProvides embedded system application solutions.\n6533\nNT$274.00\n7D\n-1.3%\n1Y\n-19.1%\nCorsair Gaming\nMarket Cap: US$957.5m\nDesigns and sells gaming and streaming peripherals, components, and systems in Europe, the Middle East, North Africa, North America, Latin America, and the Asia Pacific.\nCRSR\nUS$9.03\n7D\n-0.3%\n1Y\n48.3%\ninnoscripta\nMarket Cap: \u20ac989.0m\nProvides software-as-a-service for managing research and development (R&D) tax incentives and project management consulting in Germany.\n1INN\n\u20ac98.90\n7D\n-0.4%\n1Y\nn/a\nNippon Thompson\nMarket Cap: JP\u00a542.2b\nDevelops, manufactures, and sells needle roller bearings, linear motion rolling guides, precision positioning tables, and machine components under the IKO brand in Japan, North America, Europe, China, Singapore, Malaysia, and India.\n6480\nJP\u00a5610.00\n7D\n-0.5%\n1Y\n28.7%\nRobit Oyj\nMarket Cap: \u20ac24.0m\nEngages in the design, manufacture, and sale of drilling consumables for mining, quarrying, construction, and well drilling industries in Finland.\nROBIT\n\u20ac1.14\n7D\n-2.6%\n1Y\n-29.2%\nFinger\nMarket Cap: \u20a9123.7b\nA fintech company, provides digital financial solutions.\nA163730\n\u20a913,370.00\n7D\n4.0%\n1Y\n97.5%\ncottaLTD\nMarket Cap: JP\u00a54.7b\nEngages in manufacture and sale of confectionary food materials and food packaging materials in Japan and internationally.\n3359\nJP\u00a5442.00\n7D\n0.2%\n1Y\n17.9%\nPluxee\nMarket Cap: \u20ac2.5b\nOffers employee benefits and engagement solutions services in France, Latin America, Continental Europe, and internationally.\nPLX\n\u20ac17.38\n7D\n0.3%\n1Y\n-15.2%\nClemondo Group\nMarket Cap: SEK 135.7m\nDevelops, manufactures, and sells a range of hygiene and cleaning products for automotive, medical care, and industrial sectors in Sweden.\nCLEM\nSEK 9.80\n7D\n-3.9%\n1Y\n19.5%\nAquila Part Prod Com\nMarket Cap: RON 1.8b\nProvides distribution and logistics services in Romania, Moldova, Poland, the Netherlands, Germany, and internationally.\nAQ\nRON 1.49\n7D\n4.2%\n1Y\n11.6%\nSantos Brasil Participa\u00e7\u00f5es\nMarket Cap: R$12.1b\nProvides port container handling and logistics services in Brazil.\nSTBP3\nR$14.04\n7D\n0.6%\n1Y\n-0.07%\nALUX\nMarket Cap: \u20a9153.5b\nManufactures, supplies, and sells educational robots and drones to the education markets in South Korea.\nA475580\n\u20a911,440.00\n7D\n2.6%\n1Y\nn/a\nOld National Bancorp\nMarket Cap: US$8.1b\nOperates as the bank holding company for Old National Bank that provides consumer and commercial banking services in the United States.\nONB\nUS$20.57\n7D\n-1.0%\n1Y\n15.6%\nPerfect\nMarket Cap: US$197.6m\nAn artificial intelligence software as a service company, provides artificial intelligence (AI)- and augmented reality (AR)-powered solutions for beauty, fashion, and skincare industries worldwide.\nPERF\nUS$1.85\n7D\n-4.1%\n1Y\n-10.2%\nGEM\nMarket Cap: CN\u00a534.3b\nOperates in the waste resource comprehensive utilization industry in China and internationally.\n002340\nCN\u00a56.72\n7D\n4.0%\n1Y\n16.3%\nPrivia Health Group\nMarket Cap: US$2.5b\nOperates as a national physician-enablement company in the United States.\nPRVA\nUS$20.31\n7D\n4.3%\n1Y\n5.2%\nNingbo Sanxing Medical ElectricLtd\nMarket Cap: CN\u00a532.9b\nManufactures and sells power distribution and utilization systems in China and internationally.\n601567\nCN\u00a523.42\n7D\n2.4%\n1Y\n-19.7%\nArcticZymes Technologies\nMarket Cap: NOK 1.0b\nA life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing.\nAZT\nNOK 19.65\n7D\n0%\n1Y\n-16.9%\nGranite Ridge Resources\nMarket Cap: US$686.4m\nOperates as a non-operated oil and natural gas exploration and production company.\nGRNT\nUS$5.25\n7D\n9.6%\n1Y\n-16.5%\nSRE Holdings\nMarket Cap: JP\u00a551.2b\nEngages in the AI cloud and consulting, and real estate tech businesses in Japan.\n2980\nJP\u00a53,180.00\n7D\n0.3%\n1Y\n-18.6%"
    },
    {
      "url": "https://simplywall.st/company/id/a19b6937-cbb0-46bd-81fc-c3064ac9b509?utm_medium=finance_user&utm_campaign=cta&utm_source=yahoo&blueprint=3982594",
      "text": "WuXi Xinje ElectricLtd (603416) Stock Overview\nEngages in the development, production, and sale of industrial automation products in China and internationally. More details\n| Snowflake Score | |\n|---|---|\n| Valuation | 1/6 |\n| Future Growth | 4/6 |\n| Past Performance | 2/6 |\n| Financial Health | 6/6 |\n| Dividends | 2/6 |\n603416 Community Fair Values\nSee what others think this stock is worth. Follow their fair value or set your own to get alerts.\nWuXi Xinje Electric Co.,Ltd. Competitors\nPrice History & Performance\n| Historical stock prices | |\n|---|---|\n| Current Share Price | CN\u00a556.57 |\n| 52 Week High | CN\u00a570.26 |\n| 52 Week Low | CN\u00a527.50 |\n| Beta | 0.54 |\n| 1 Month Change | -1.43% |\n| 3 Month Change | -16.51% |\n| 1 Year Change | 83.97% |\n| 3 Year Change | 20.31% |\n| 5 Year Change | -20.83% |\n| Change since IPO | 208.16% |\nRecent News & Updates\nRecent updates\nUnpleasant Surprises Could Be In Store For WuXi Xinje Electric Co.,Ltd.'s (SHSE:603416) Shares\nMar 12WuXi Xinje ElectricLtd (SHSE:603416) Could Easily Take On More Debt\nFeb 24Estimating The Intrinsic Value Of WuXi Xinje Electric Co.,Ltd. (SHSE:603416)\nJan 24Investors Could Be Concerned With WuXi Xinje ElectricLtd's (SHSE:603416) Returns On Capital\nJan 03WuXi Xinje Electric Co.,Ltd.'s (SHSE:603416) Low P/E No Reason For Excitement\nOct 16Is WuXi Xinje ElectricLtd (SHSE:603416) Using Too Much Debt?\nSep 30WuXi Xinje Electric Co.,Ltd.'s (SHSE:603416) Share Price Is Matching Sentiment Around Its Earnings\nJun 26WuXi Xinje ElectricLtd (SHSE:603416) Has A Rock Solid Balance Sheet\nMay 28WuXi Xinje ElectricLtd's (SHSE:603416) Conservative Accounting Might Explain Soft Earnings\nApr 26The Returns On Capital At WuXi Xinje ElectricLtd (SHSE:603416) Don't Inspire Confidence\nMar 28There's No Escaping WuXi Xinje Electric Co.,Ltd.'s (SHSE:603416) Muted Earnings Despite A 33% Share Price Rise\nMar 06WuXi Xinje ElectricLtd (SHSE:603416) Seems To Use Debt Quite Sensibly\nFeb 28Shareholder Returns\n| 603416 | CN Electronic | CN Market | |\n|---|---|---|---|\n| 7D | 2.9% | 4.2% | 2.2% |\n| 1Y | 84.0% | 58.3% | 36.8% |\nReturn vs Industry: 603416 exceeded the CN Electronic industry which returned 54% over the past year.\nReturn vs Market: 603416 exceeded the CN Market which returned 34.9% over the past year.\nPrice Volatility\n| 603416 volatility | |\n|---|---|\n| 603416 Average Weekly Movement | 6.2% |\n| Electronic Industry Average Movement | 5.1% |\n| Market Average Movement | 4.8% |\n| 10% most volatile stocks in CN Market | 8.4% |\n| 10% least volatile stocks in CN Market | 2.8% |\nStable Share Price: 603416 has not had significant price volatility in the past 3 months compared to the CN market.\nVolatility Over Time: 603416's weekly volatility (6%) has been stable over the past year.\nAbout the Company\n| Founded | Employees | CEO | Website |\n|---|---|---|---|\n| 2008 | 2,611 | Xin Li | www.xinje.com |\nWuXi Xinje Electric Co.,Ltd. engages in the development, production, and sale of industrial automation products in China and internationally. The company offers programmable logic controller, human-machine interface, integrated controller, special modules, and integral controller for industrial control; and server system, stepping system, inverter for sport control.\nWuXi Xinje Electric Co.,Ltd. Fundamentals Summary\n| 603416 fundamental statistics | |\n|---|---|\n| Market cap | CN\u00a58.81b |\n| Earnings (TTM) | CN\u00a5230.09m |\n| Revenue (TTM) | CN\u00a51.76b |\nIs 603416 overvalued?\nSee Fair Value and valuation analysisEarnings & Revenue\n| 603416 income statement (TTM) | |\n|---|---|\n| Revenue | CN\u00a51.76b |\n| Cost of Revenue | CN\u00a51.11b |\n| Gross Profit | CN\u00a5646.53m |\n| Other Expenses | CN\u00a5416.44m |\n| Earnings | CN\u00a5230.09m |\nLast Reported Earnings\nMar 31, 2025\nNext Earnings Date\nAug 28, 2025\n| Earnings per share (EPS) | 1.48 |\n| Gross Margin | 36.80% |\n| Net Profit Margin | 13.10% |\n| Debt/Equity Ratio | 0% |\nHow did 603416 perform over the long term?\nSee historical performance and comparisonDividends\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/11 02:32 |\n| End of Day Share Price | 2025/08/11 00:00 |\n| Earnings | 2025/03/31 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nWuXi Xinje Electric Co.,Ltd. is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| Peng Jiang | China International Capital Corporation Limited |\n| Zishuo Li | Citic Securities Co., Ltd. |\n| Xiang Huang | Credit Suisse |"
    }
  ],
  "argos_summary": "The Asian tech market is witnessing significant growth, with notable performances from companies like Essex Bio-Technology and WuXi Xinje Electric Co., Ltd. Essex Bio-Technology, with a market cap of approximately HK$3.16 billion, is expected to see a 10.2% revenue increase and a 12% annual earnings growth, despite underperforming the biotech industry last year. Meanwhile, WuXi Xinje Electric, valued at CN\u00a58.81 billion, focuses on industrial automation and has shown resilience with a revenue growth rate of 11.8% per year, although its earnings have declined at an average annual rate of -7.7%.",
  "argos_id": "0A69AASB2"
}